What is Bacil Pharma share price return in the past 10 years?

Bacil Pharma Ltd share price has appreciated 29.6% annually (CAGR) over the past ten years.

Bacil Pharma Ltd - Stock Valuation and Financial Performance

Name: Bacil Pharma
Brand: Bacil Pharma

BSE: 524516 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

Bacil Pharma Share Price

₹18.85 0.36 1.95%
as on 19-Apr'24 14:30

DeciZen - make an informed investing decision on Bacil Pharma

Based on:

Data

M-Cap below 100cr DeciZen not available

Bacil Pharma stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

10.9 Cr.

52-wk low:

4.7

52-wk high:

18.5

Is Bacil Pharma Ltd an attractive stock to invest in?

1. Is Bacil Pharma Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Bacil Pharma Ltd is a below average quality company.

2. Is Bacil Pharma Ltd undervalued or overvalued?

The key valuation ratios of Bacil Pharma Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Bacil Pharma Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Bacil Pharma Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Bacil Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	-0.9%	-0.5%	-1%	-1.1%	-29.3%	-10.9%	-7.1%	-8.7%	-87%	-11.4%	-
Value Creation Index ⓘ	-1.1	-1.0	-1.1	-1.1	-3.1	-1.8	-1.5	-1.6	-7.2	-1.8	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0	0	0	0	0	0	0	0	0
Sales YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	NA	NA	-
Adj EPS ⓘ	-0.1	-0.1	-0.1	-0.1	-2.3	-0.4	-0.2	-0.2	-2.1	-0.2	-0.2
YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	NA	NA	-
BVPS (₹) ⓘ	10	9.9	8.6	9.8	2.7	2.2	1.3	1.3	1	0.8	0.8
Adj Net Profit ⓘ	-0.1	0	-0.1	-0.1	-1.3	-0.2	-0.1	-0.1	-1.2	-0.1	0
Cash Flow from Ops. ⓘ	-0.1	0.3	0.1	0	1.4	-0.3	-0.4	-0.4	-4	-0.2	-
Debt/CF from Ops. ⓘ	-1.6	0.6	4.5	-66.6	0	-0.3	-0.5	-0.4	-0	-0.1	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	NA	NA
Adj EPS ⓘ	NA	NA	NA	NA
BVPSⓘ	-24.6%	-22.1%	-15%	-22%
Share Price	29.6%	52.3%	63%	257.7%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	-0.9	-0.5	-1	-1.2	-30.8	-11.1	-8.1	-10.1	-94	-11.8	-20.9
Op. Profit Mgn % ⓘ	0	0	0	0	0	0	0	0	0	0	NAN
Net Profit Mgn % ⓘ	0	0	0	0	0	0	0	0	0	0	-INF
Debt to Equity ⓘ	0	0	0.1	0.1	0	0.1	0.1	0.1	0	0	-
Working Cap Days ⓘ	0	0	0	0	0	0	0	0	0	0	0
Cash Conv. Cycle ⓘ	0	0	0	0	0	0	0	0	0	0	0

Recent Performance Summary

No data to display

Return on Equity is Poor

Sales growth has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Bacil Pharma Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-0.2	-
TTM Sales (₹ Cr.)	0	-
BVPS (₹.) ⓘ	0.8	-
Reserves (₹ Cr.) ⓘ	-5	-
P/BV ⓘ	24.57	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	4.68 / 18.49
All Time Low / High (₹)	0.80 / 25.00
Market Cap (₹ Cr.)	10.9
Equity (₹ Cr.)	5.9
Face Value (₹)	10
Industry PE ⓘ	47.6

Management X-Ray of Bacil Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Bacil Pharma

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Bacil Pharma

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	0	0	0	0	0	0	0	0	0	0
Operating Expenses ⓘ	0.16	0.11	0.13	0.17	0.30	0.43	0.44	0.30	3.91	0.21
Manufacturing Costs	0	0	0	0.01	0.03	0.01	0	0	0	0
Material Costs	0	0	0	0	0	0	0	0	0	0
Employee Cost	0.03	0.03	0.04	0.08	0.13	0.08	0.09	0.05	0.06	0.09
Other Costs ⓘ	0.13	0.08	0.09	0.09	0.14	0.34	0.34	0.25	3.85	0.12
Operating Profit ⓘ	-0.16	-0.11	-0.13	-0.17	-0.30	-0.43	-0.44	-0.30	-3.91	-0.21
Operating Profit Margin (%)	-	-	-	-	-	-	-	-	-	-
Other Income ⓘ	0.06	0.08	0.06	0.17	0.27	0.09	0.14	0.07	0.06	0.11
Interest ⓘ	0	0	0	0	0.03	0	0.01	0	0	0
Depreciation ⓘ	0.01	0	0	0	0.01	0.01	0.01	0	0	0
Exceptional Items ⓘ	0	0	0	0	-3.69	0	0	0	0	0
Profit Before Tax ⓘ	-0.11	-0.03	-0.07	0	-3.75	-0.34	-0.32	-0.24	-3.86	-0.10
Tax ⓘ	0	0	0	0	0	0	0	0	0	0
Profit After Tax	-0.11	-0.03	-0.07	0	-3.75	-0.34	-0.32	-0.24	-3.86	-0.10
PAT Margin (%)	-	-	-	-	-	-	-	-	-	-
Adjusted EPS (₹)	-0.2	-0.1	-0.1	0.0	-6.4	-0.6	-0.5	-0.4	-6.6	-0.2
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	6.50	6.47	6.40	6.43	2.24	1.91	1.39	1.39	1.22	1.10
Share Capital ⓘ	6.53	6.53	6.53	6.53	6.53	6.53	6.53	6.53	6.53	6.53
Reserves ⓘ	-0.03	-0.06	-0.13	-0.09	-4.29	-4.62	-5.14	-5.14	-5.30	-5.43
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	0.08	0.14	0.27	0.31	0	0.10	0.17	0.18	0.03	0.02
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	0.08	0.14	0.27	0.31	0	0.10	0.17	0.18	0.03	0.02
Trade Payables	0	0.01	0	0	0	0.04	0.04	0.01	0.01	0
Others Liabilities ⓘ	0.01	0.01	0.02	0.02	2.41	2.39	2.32	2.40	-0.11	-0.11
Total Liabilities ⓘ	6.59	6.62	6.69	6.77	4.65	4.43	3.91	3.98	1.16	1.01
Fixed Assets
Gross Block	0.02	0.01	5.26	5.95	2.56	2.56	2.56	2.56	0.06	0.06
Accumulated Depreciation	0.01	0.01	0.01	0.01	0.02	0.03	0.04	0.04	0.05	0.05
Net Fixed Assetsⓘ	0.01	0.01	5.25	5.94	2.53	2.53	2.52	2.51	0.01	0.01
CWIP ⓘ	5.80	5.88	0	0	0	0	0	0	0	0
Investmentsⓘ	0.25	0.51	0.51	0.54	1.15	0.96	0.43	0.37	0.31	0.43
Inventories	0	0	0	0	0	0	0	0	0	0
Trade Receivables	0.01	0	0	0	0.01	0	0	0	0	0
Cash Equivalents	0.09	0.02	0.02	0.04	0.27	0.09	0.04	0.10	0.23	0.03
Others Assetsⓘ	0.43	0.21	0.91	0.25	0.68	0.86	0.92	0.99	0.61	0.55
Total Assets ⓘ	6.59	6.62	6.69	6.77	4.65	4.43	3.91	3.98	1.16	1.01

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	-0.05	0.26	0.06	0	1.44	-0.30	-0.38	-0.40	-4.01	-0.15
PBT ⓘ	-0.11	-0.03	-0.07	0	-3.75	-0.34	-0.32	-0.24	-3.86	-0.10
Adjustment ⓘ	0.01	0	0	0	3.43	-0.09	-0.13	-0.14	-0.05	-0.03
Changes in Working Capital ⓘ	0.05	0.29	0.13	-0.01	1.76	0.13	0.07	-0.02	-0.1	-0.02
Tax Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ	0	-0.33	-0.05	0.02	-1.20	0.28	0.39	0.53	3.81	-0.12
Capex	0	0	-5.24	0	-0.30	0	0	0.39	0	0
Net Investments	0.08	-0.26	0	0.02	-0.93	0.19	0.25	0	3.75	-0.15
Others ⓘ	-0.07	-0.07	5.19	0	0.03	0.09	0.14	0.14	0.06	0.03
Cash Flow From Financing Activityⓘ	0	0	0	0	0	-0.16	-0.06	-0.07	0.33	0.06
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	-0.16	-0.06	-0.07	0.33	0.06
Net Cash Flow ⓘ	-0.05	-0.07	0.01	0.02	0.23	-0.18	-0.05	0.06	0.13	-0.20

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	-1.84	-0.54	-1.23	-0.04	-101.39	-23.83	-31.16	-31.82	-575.48	-19.41
ROCE (%)	-1.65	-0.48	-1.06	-0.03	-83.02	-16.18	-17.2	-15.05	-273.27	-8.44
Asset Turnover Ratio	0	0	0	0	0	0	0	0	0	0
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	0	0	0	0	0	0	0	0	0	0
Inventory Days	0	0	0	0	0	0	0	0	0	0
Payable Days	0	0	0	0	0	0	0	0	0	0

Bacil Pharma Ltd Stock News

Bacil Pharma Ltd FAQs

What is the share price of Bacil Pharma?

Company share prices are keep on changing according to the market conditions. The closing price of Bacil Pharma on 19-Apr-2024 14:30 is ₹18.85.

What is the market cap of Bacil Pharma?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 19-Apr-2024 14:30 the market cap of Bacil Pharma stood at ₹10.89.

What is the P/E ratio of Bacil Pharma?

The latest P/E ratio of Bacil Pharma as of 19-Apr-2024 14:30 is 0.00.

What is the P/B ratio of Bacil Pharma?

The latest P/B ratio of Bacil Pharma as of 19-Apr-2024 14:30 is 24.57.

What is the 52-week high and low of Bacil Pharma?

The 52-week high of Bacil Pharma is ₹18.49 and the 52-week low is ₹4.68.

What is the TTM revenue of Bacil Pharma?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Bacil Pharma is ₹0.00 ( Cr.) .

About Bacil Pharma Ltd

Bacil Pharma was incorporated in the year 1987. Its plant is located at Lote-Parshuraram, an industrial area about 250 kilometer from Mumbai city.

Business profile:

The company manufactures bulk pharmaceutical/ chemical manufacturing heavy, medium and fine chemicals. The Lote-Parshuraram plant also has manufacture facility for herbal extract and drug intermediates.